Related Experiment Video
Updated: Jun 19, 2025

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer
Published on: February 9, 2024
Changing the paradigm: Elimination - Not only of cervical cancer
Jacob Bornstein1,2, Koray Gorkem Sacinti3,4, Mario Preti5
1The Research Institute of Galilee Medical Center, Galilee Medical Center, Nahariya, Israel.
Abstract:
The WHO's initiative to eliminate cervical cancer by 2030 does not address the increasing incidence of vulvar, anal, and oropharyngeal cancers linked to high-risk HPV. Currently, the prevention of these three cancers faces various obstacles, such as a lack of specialized screening programs, well-defined management guidelines, and widespread public awareness. Without any interventions, the incidence of these three cancers will likely rise in the upcoming years, increasingly affecting younger individuals. We recommend expanding the WHO's initiative to include vulvar, anal, and oropharyngeal cancers. This involves developing screening and management protocols similar to those for cervical cancer, implementing gender-neutral HPV vaccination programs, establishing clear referral pathways to specialized centers, promoting public awareness, and providing education to healthcare providers and high-risk individuals.
Insights
The WHO
Area of Science:
- Oncology
- Public Health
- Infectious Diseases
Background:
- The World Health Organization's (WHO) initiative aims to eliminate cervical cancer by 2030.
- This initiative overlooks rising rates of vulvar, anal, and oropharyngeal cancers caused by high-risk human papillomavirus (HPV).
- Current prevention strategies for these cancers are hindered by a lack of screening programs, clear management guidelines, and public awareness.
Purpose of the Study:
- To highlight the increasing incidence of HPV-linked vulvar, anal, and oropharyngeal cancers.
- To advocate for the expansion of the WHO's cancer elimination initiative.
- To propose comprehensive strategies for preventing these cancers.
Main Methods:
- Review of current public health initiatives and cancer incidence data.
- Analysis of obstacles in current prevention and management of HPV-related cancers.
- Development of recommendations for expanded WHO strategies.
Main Results:
- Vulvar, anal, and oropharyngeal cancers linked to high-risk HPV are increasing.
- These cancers disproportionately affect younger populations.
- Existing prevention frameworks are inadequate for these specific HPV-driven malignancies.
Conclusions:
- The WHO's cervical cancer elimination strategy must be broadened to encompass vulvar, anal, and oropharyngeal cancers.
- Implementing gender-neutral HPV vaccination, standardized screening, and enhanced public awareness is crucial.
- Proactive interventions are necessary to curb the rising incidence of these cancers and protect public health.
Related Concept Videos
Preventive Healthcare Services
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Methods Of Healthcare Delivery System
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Birth Control Methods

